Sclerostin Quo Vadis? - Is This a Useful Long-Term Mortality Parameter in Prevalent Hemodialysis Patients?

• Glavni autori: Albina Nowak (Autor), Ferruh Artunc (Autor), Andreas L. Serra (Autor), Emily Pollock (Autor), Pierre-Alexandre Krayenbühl (Autor), Christian Müller (Autor), Björn Friedrich (Autor)
• Format: Knjiga
• Izdano: Karger Publishers, 2015-05-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Background/Aims: Cardiovascular calcification contributes to the increased mortality in hemodialysis patients. Sclerostin was identified as an antianabolic bone factor causing soft tissue calcification. Data on prospective large-scale studies associating sclerostin with mortality in hemodialysis pat...